7. FEDERAL AND STATE LEVEL RECOGNITION: The acknowledgment by federal agencies such as the FDA and NIDA, along with the widespread acceptance of medical marijuana programs at the state level, underscores the recognized medical utility and relative safety of marijuana •
CONCLUSION
The recommendation to reschedule marijuana to Schedule III is supported by its lower potential for abuse compared to Schedule I and II substances, its accepted medical use, and its manageable safety profile under medical supervision. The mild nature of its withdrawal symptoms and the supportive stance of various medical organizations further justify its rescheduling. This change would facilitate more research and potentially expand the medical use of marijuana while maintaining appropriate controls to mitigate risks of abuse and dependence. SUMMARY OF NEGATIVE AND UNCERTAIN CONCLUSIONS FOR RECOMMENDING MARIJUANA'S RESCHEDULING TO SCHEDULE III The "Basis for the Recommendation to Reschedule Marijuana into Schedule III - HHS Report" outlines several negative and uncertain conclusions regarding the rescheduling of marijuana to Schedule III. Below is a summary of these conclusions for distribution purposes:
NEGATIVE CONCLUSIONS
1. LACK OF HIGH QUALITY EVIDENCE: Many professional organizations and systematic reviews indicate that the evidence supporting the therapeutic benefits of marijuana is of low quality. For example, the American Academy of Neurology and the American Epilepsy Society both highlight insufficient scientific evidence to support the medical use of cannabis for neurologic disorders and epilepsy, respectively • Studies often rely on synthetic THC rather than botanical marijuana, which limits the applicability of findings to real-world medical use of marijuan • 2. PSYCHIATRIC RISKS: The American Psychiatric Association does not endorse cannabis as a medicine and notes its association with the onset of psychiatric disorders. This organization specifically recommends against its medical use due to the potential exacerbation of psychiatric conditions • 3. PHYSICAL AND PSYCHOLOGICAL DEPENDENCE: Chronic use of marijuana can lead to both physical and psychological dependence. Symptoms of marijuana withdrawal, such as sleep difficulties, irritability, and decreased appetite, are relatively mild but do indicate a potential for dependence • 4. ADVERSE EFFECTS: Common adverse effects reported include dry mouth, headaches, psychoactive euphoria, agitation, and palpitations. Severe adverse events, while uncommon, do occur and pose risks to patients •
PAGE 4
Made with FlippingBook - professional solution for displaying marketing and sales documents online